Medical ＆Biological Laboratories Co., Ltd. (MBL), a JSR Life Sciences Company, announced on April 4, 2022 launch of a new kit for the detection of anti-Integrin αvβ6 antibodies.

For more information on 'Launch of a New Kit for the Detection of anti-Integrin αvβ6 Antibodies', visit MBL's webpage on the new service.
https://www.mblbio.com/e/ir/2022/img/Press20220404E.pdf

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

JSR Corporation published this content on 04 April 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 April 2022 06:23:10 UTC.